(Q36711798)

15 August 2017

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival (English)

1 reference

15 August 2017

anti-retroviral agent

0 references

0 references

Mariam O Fofana

6

0 references

Rochelle P. Walensky

Rochelle P Walensky

1

0 references

Elena Losina

Elena Losina

5

0 references

Robin Wood

2

Robin Wood

1 reference

15 August 2017

3

Milton C Weinstein

1 reference

15 August 2017

7

Sue J Goldie

1 reference

15 August 2017

12

Kenneth A Freedberg

1 reference

15 August 2017

9

Yazdan Yazdanpanah

1 reference

15 August 2017

11

A David Paltiel

1 reference

15 August 2017

10

Bingxia Wang

1 reference

CEPAC-International Investigators

15 August 2017

13

CEPAC-International Investigators

1 reference

15 August 2017

8

Nomita Divi

1 reference

15 August 2017

Neil A Martinson

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Journal of Infectious Diseases

15 August 2017

1 reference

15 August 2017

197

1 reference

15 August 2017

9

1 reference

15 August 2017

1324-1332

1 reference

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Lessons learned from use of highly active antiretroviral therapy in Africa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Total lymphocyte count as a surrogate for CD4+ lymphocyte count in African patients coinfected with HIV and tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Scaling up antiretroviral treatment in resource-poor settings

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2423492

CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1086%2F587184

Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1086%2F587184

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/18422445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

South Africa's "rollout" of highly active antiretroviral therapy: a critical assessment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18422445

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1086/587184

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18422445

1 reference